DK377084A - Hormonpraeparat til behandling af menopausale forstyrrelser - Google Patents

Hormonpraeparat til behandling af menopausale forstyrrelser Download PDF

Info

Publication number
DK377084A
DK377084A DK377084A DK377084A DK377084A DK 377084 A DK377084 A DK 377084A DK 377084 A DK377084 A DK 377084A DK 377084 A DK377084 A DK 377084A DK 377084 A DK377084 A DK 377084A
Authority
DK
Denmark
Prior art keywords
hormone preparations
menopausal disorders
treating menopausal
dosages
prod
Prior art date
Application number
DK377084A
Other languages
English (en)
Other versions
DK165390B (da
DK165390C (da
DK377084D0 (da
Inventor
Earl Robert Plunkett
Bernard Martin Joseph Wolfe
Original Assignee
Earl Robert Plunkett
Wolfe Bernard M J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27060286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK377084(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Earl Robert Plunkett, Wolfe Bernard M J filed Critical Earl Robert Plunkett
Publication of DK377084D0 publication Critical patent/DK377084D0/da
Publication of DK377084A publication Critical patent/DK377084A/da
Publication of DK165390B publication Critical patent/DK165390B/da
Priority to DK200400365A priority Critical patent/DK175317B1/da
Application granted granted Critical
Publication of DK165390C publication Critical patent/DK165390C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK198403770A 1983-08-05 1984-08-03 Anvendelse af et progestogen og et østrogen til fremstllling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt DK165390C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200400365A DK175317B1 (da) 1983-08-05 2004-03-04 Anvendelse af et progestogen og et östrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52083483A 1983-08-05 1983-08-05
US52083483 1983-08-05
US63523684 1984-07-27
US06/635,236 US4826831A (en) 1983-08-05 1984-07-27 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Publications (4)

Publication Number Publication Date
DK377084D0 DK377084D0 (da) 1984-08-03
DK377084A true DK377084A (da) 1985-02-06
DK165390B DK165390B (da) 1992-11-23
DK165390C DK165390C (da) 2004-04-26

Family

ID=27060286

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198403770A DK165390C (da) 1983-08-05 1984-08-03 Anvendelse af et progestogen og et østrogen til fremstllling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt
DK200400365A DK175317B1 (da) 1983-08-05 2004-03-04 Anvendelse af et progestogen og et östrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK200400365A DK175317B1 (da) 1983-08-05 2004-03-04 Anvendelse af et progestogen og et östrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt

Country Status (12)

Country Link
US (2) US4826831A (da)
EP (1) EP0136011B2 (da)
AT (1) ATE147987T1 (da)
CA (1) CA1240927A (da)
DE (5) DE10075037I2 (da)
DK (2) DK165390C (da)
IL (1) IL72556A (da)
LU (5) LU90107I2 (da)
MX (1) MX9203720A (da)
NL (5) NL970026I1 (da)
NZ (1) NZ209066A (da)
PH (1) PH24052A (da)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
CH674618A5 (da) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE3864210D1 (de) * 1987-07-06 1991-09-19 Akzo Nv Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
PH30747A (en) * 1989-03-10 1997-10-17 Endorech Inc Combination therapy for the treatment of estrogen sensitive disease.
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US6037339A (en) * 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19510861A1 (de) * 1995-03-16 1996-09-19 Schering Ag Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
WO2000003678A2 (en) * 1998-07-17 2000-01-27 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for contraception
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
WO2000021511A2 (en) * 1998-10-09 2000-04-20 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US20020151530A1 (en) 2000-12-22 2002-10-17 Leonard Thomas W. Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
EP1368037A2 (en) * 2001-03-16 2003-12-10 Wyeth Estrogen replacement therapy
NZ528373A (en) * 2001-03-16 2005-07-29 Wyeth Corp Hormone replacement therapy
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
US8658627B2 (en) 2001-04-25 2014-02-25 The Regents Of The University Of California Pregnancy hormone combination for treatment of autoimmune diseases
US20030004145A1 (en) 2001-05-16 2003-01-02 Leonard Thomas W. Treatment of conditions relating to hormone deficiencies by administration of progestins
JP2004521951A (ja) * 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
WO2003018026A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
EP2305230B1 (en) 2001-12-05 2015-11-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy
MXPA04009671A (es) * 2002-04-03 2005-01-25 Barr Lab Inc Terapia de reduccion escalonada con estrogenos.
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
RS20050184A (sr) * 2002-08-28 2007-11-15 Robert Casper Režim zamene estrogena
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
CA2524474A1 (en) * 2003-05-02 2004-11-18 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
JP2007534622A (ja) * 2003-07-16 2007-11-29 デュラメド ファーマシューティカルズ インコーポレーティッド 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法
JP4880465B2 (ja) * 2003-09-29 2012-02-22 ノボ・ノルディスク・フェムケア・アーゲー 向上した安定性のプロゲストーゲン製剤
AU2004275469B2 (en) 2003-09-29 2010-07-15 Novo Nordisk Health Care Ag HRT formulations
JP2008500340A (ja) * 2004-05-26 2008-01-10 ワイス 月経前不機嫌性障害の処置のための組成物および方法
DE102004026679A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
AU2006330846A1 (en) * 2005-12-27 2007-07-05 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral
KR20130097073A (ko) 2010-04-15 2013-09-02 바이엘 인텔렉쳐 프로퍼티 게엠베하 초저-용량의 ｈｒｔ용 고체 경구 투여 형태
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10369158B2 (en) 2014-04-28 2019-08-06 The Regents Of The University Of California Pharmaceutical packaging for estriol therapy
EP3137087B1 (en) * 2014-04-28 2023-09-06 The Regents of the University of California Estrogen combination for treatment of multiple sclerosis
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10821117B2 (en) 2014-09-02 2020-11-03 The Regents Of The University Of California Estrogen therapy for brain gray matter atrophy and associated disability
CA2962921A1 (en) 2014-09-29 2016-04-07 The Regents Of The University Of California Compositions and methods for maintaining cognitive function
EP3277285B1 (en) 2015-03-30 2024-07-17 The Regents of the University of California Estriol for reducing cortical gray matter atrophy
LT3701944T (lt) 2015-06-18 2022-04-11 Estetra Srl Burnoje disperguojamas dozavimo vienetas, kurio sudėtyje yra estetrolio komponentas
ES2671160T3 (es) 2015-06-18 2018-06-05 Mithra Pharmaceuticals S.A. Unidad de dosificación orodispersable que contiene un componente estetrol
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
SG11202009725XA (en) 2018-04-19 2020-11-27 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US12138270B2 (en) 2021-09-07 2024-11-12 Millicent Pharma Limited Contraceptive regimen including reduced level of estrogen
USD1098920S1 (en) * 2023-10-19 2025-10-21 Pepsico, Inc. Bottle

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
GB1578340A (en) * 1977-11-15 1980-11-05 Normalair Garrett Ltd Mechanical hands eg for diving apparatus
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms

Also Published As

Publication number Publication date
NL300033I2 (nl) 2004-04-01
LU90343I2 (fr) 1999-03-29
MX9203720A (es) 1992-07-31
DE10199010I2 (de) 2010-01-28
EP0136011B2 (en) 2004-06-09
CA1240927A (en) 1988-08-23
DE10199001I1 (de) 2002-03-14
DE3486442T3 (de) 2005-05-12
EP0136011A3 (en) 1986-07-16
DK165390B (da) 1992-11-23
DE3486442T2 (de) 1997-06-05
NL970026I1 (nl) 1997-10-01
DE10199001I2 (de) 2010-07-08
NL980038I2 (nl) 2005-06-01
NL970037I1 (nl) 1998-02-02
DE3486442D1 (de) 1997-03-06
DK200400365A (da) 2004-03-04
IL72556A (en) 1989-05-15
IL72556A0 (en) 1984-11-30
LU90697I2 (fr) 2001-02-13
NZ209066A (en) 1988-01-08
DE10199010I1 (de) 2002-05-08
DE10075037I1 (de) 2001-03-01
US4826831A (en) 1989-05-02
DK175317B1 (da) 2004-08-16
NL300022I1 (nl) 2001-01-02
USRE36247E (en) 1999-07-06
NL970037I2 (nl) 2004-04-01
DK165390C (da) 2004-04-26
NL300022I2 (nl) 2004-04-01
DE19775086I2 (de) 2001-08-23
DK377084D0 (da) 1984-08-03
PH24052A (en) 1990-03-05
LU90107I2 (fr) 1997-12-17
NL300033I1 (nl) 2001-03-01
ATE147987T1 (de) 1997-02-15
EP0136011B1 (en) 1997-01-22
NL980038I1 (nl) 1999-02-01
LU91096I2 (fr) 2004-11-30
LU90696I2 (fr) 2001-02-13
EP0136011A2 (en) 1985-04-03
DE10075037I2 (de) 2010-01-28

Similar Documents

Publication Publication Date Title
DK377084A (da) Hormonpraeparat til behandling af menopausale forstyrrelser
GR3031716T3 (en) Immunogens against gonadotropin releasing hormone
JPS5329076A (en) Plasma treating apparatus of semiconductor substrates
JPS51136208A (en) Voice recognition device for limited words
JPS5231565A (en) Sewage disposal
JPS5250659A (en) Timing output generation circuit
JPS5228160A (en) Wagon style pre treatment system
JPS51122253A (en) Branching apparatus
JPS51130189A (en) Synchronizing equipment
JPS522904A (en) Rails switching apparatus
JPS5244975A (en) Super heavy article transporting apparatus
JPS5225291A (en) Fixing or tightening fittings for wire, etc.
JPS5215009A (en) Current supply system of linearmotor railway
JPS5323091A (en) Terminal for branch
JPS5284055A (en) Attachment for a hair dryer
JPS51136236A (en) Wave form input output device
JPS51138841A (en) Dc feed system
JPS51150458A (en) Device for fixing a mirror
JPS51143843A (en) Load limiting apparatus
JPS52119121A (en) Auto-clear circuit
JPS51121164A (en) Means for regulating power source and load
JPS51139063A (en) Discharging device of parts

Legal Events

Date Code Title Description
PUP Patent expired
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2004 00013

Filing date: 20040519

Expiry date: 20090803

Spc suppl protection certif: CA 2004 00017

Filing date: 20040519

Expiry date: 20090803

Spc suppl protection certif: CA 2004 00015

Filing date: 20040519

Expiry date: 20090803

CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2004 00014

Filing date: 20040519

Expiry date: 20090803

CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2004 00016

Filing date: 20040519

Expiry date: 20090803

CTFG Supplementary protection certificate (spc) issued

Free format text: PRODUCT NAME: ESTRADIOL-HEMIHYDRAT,DYDROGESTERON

Spc suppl protection certif: CA 2004 00014

Filing date: 20040519

Free format text: PRODUCT NAME: ESTRADIOLVALERAT,MEDROXYPROGESTERONACETAT

Spc suppl protection certif: CA 2004 00015

Filing date: 20040519

Free format text: PRODUCT NAME: ESTRADIOL,MEDROXYPROGESTERONACETAT

Spc suppl protection certif: CA 2004 00016

Filing date: 20040519

CTFW Supplementary protection certificate (spc) withdrawn, refused or deemed withdrawn

Free format text: PRODUCT NAME: NORETHISTERONACETAT,ETHINYLESTRADIOL

Spc suppl protection certif: CA 2004 00013

Filing date: 20040519